DK0429676T3 - - Google Patents
Info
- Publication number
- DK0429676T3 DK0429676T3 DK90909377.5T DK90909377T DK0429676T3 DK 0429676 T3 DK0429676 T3 DK 0429676T3 DK 90909377 T DK90909377 T DK 90909377T DK 0429676 T3 DK0429676 T3 DK 0429676T3
- Authority
- DK
- Denmark
- Prior art keywords
- those caused
- cerebral
- cerebral ischemia
- brain functions
- brain
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP15364689 | 1989-06-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0429676T3 true DK0429676T3 (da) | 1997-03-10 |
Family
ID=15567085
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK90909377.5T DK0429676T3 (da) | 1989-06-16 | 1990-06-14 |
Country Status (8)
Country | Link |
---|---|
US (1) | US5182276A (da) |
EP (1) | EP0429676B1 (da) |
KR (1) | KR0133553B1 (da) |
AT (1) | ATE142881T1 (da) |
CA (1) | CA2032487A1 (da) |
DE (1) | DE69028603T2 (da) |
DK (1) | DK0429676T3 (da) |
WO (1) | WO1990015607A1 (da) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5182276A (en) * | 1989-06-16 | 1993-01-26 | Santen Pharmaceutical Co., Ltd. | Nootropic agent |
EA019020B1 (ru) * | 2011-07-12 | 2013-12-30 | Институт Химических Проблем Им. М.Ф. Нагиева Национальной Академии Наук Азербайджана | Способ лечения нарушений гемостаза при ушибах головного мозга |
WO2024012554A1 (zh) * | 2022-07-14 | 2024-01-18 | 上海日馨医药科技股份有限公司 | Tpk激动剂及使用其治疗神经退行性疾病的方法 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3166554A (en) * | 1965-01-19 | Certificate of correction | ||
US3715353A (en) * | 1970-10-12 | 1973-02-06 | Squibb & Sons Inc | (aminoalkoxy-benzylidene)-2h-benzothiazine-3(4h)-ones and related compounds |
US3725403A (en) * | 1970-10-20 | 1973-04-03 | Squibb & Sons Inc | Benzothiazine derivatives |
JPS5651465A (en) * | 1979-10-02 | 1981-05-09 | Yoshitomi Pharmaceut Ind Ltd | Benzothiazine derivative |
JPS59148771A (ja) * | 1983-02-09 | 1984-08-25 | Santen Pharmaceut Co Ltd | ベンゾチアジン誘導体 |
DE3347173A1 (de) * | 1983-12-27 | 1985-07-04 | Hoechst Ag, 6230 Frankfurt | Neue benzothiazin-derivate, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung |
JPS60166674A (ja) * | 1984-02-09 | 1985-08-29 | Santen Pharmaceut Co Ltd | ベンゾチアジン誘導体 |
EP0186310A1 (en) * | 1984-11-28 | 1986-07-02 | Takeda Chemical Industries, Ltd. | 1,4-Benzothiazine Derivatives, their production and use |
JPH0625186B2 (ja) * | 1985-03-19 | 1994-04-06 | 参天製薬株式会社 | 2−アリ−ルベンゾチアジン誘導体 |
KR890004196B1 (ko) * | 1985-07-29 | 1989-10-27 | 산텐세이야꾸가부시끼가이샤 | 신규 벤조티아진 유도체의 제조방법 |
US4654372A (en) * | 1986-01-10 | 1987-03-31 | Warner-Lambert Company | Method for using verapamil for treating stroke |
DE3614355A1 (de) * | 1986-04-28 | 1987-10-29 | Hoechst Ag | Neue benzothiazinon-derivate, verfahren zu ihrer herstellung , sie enthaltende arzneimittel und deren verwendung |
DE3614363A1 (de) * | 1986-04-28 | 1987-10-29 | Hoechst Ag | Benzothiazinon-derivate, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung |
JPS6357578A (ja) * | 1986-08-27 | 1988-03-12 | Santen Pharmaceut Co Ltd | ベンゾチアジン誘導体 |
JPH068284B2 (ja) * | 1986-08-27 | 1994-02-02 | 参天製薬株式会社 | 3−チオキソ−ベンゾチアジン誘導体 |
JPS63104969A (ja) * | 1986-10-23 | 1988-05-10 | Santen Pharmaceut Co Ltd | 含硫黄複素環化合物 |
US5182276A (en) * | 1989-06-16 | 1993-01-26 | Santen Pharmaceutical Co., Ltd. | Nootropic agent |
-
1990
- 1990-06-14 US US07/623,657 patent/US5182276A/en not_active Expired - Fee Related
- 1990-06-14 EP EP90909377A patent/EP0429676B1/en not_active Expired - Lifetime
- 1990-06-14 CA CA002032487A patent/CA2032487A1/en not_active Abandoned
- 1990-06-14 KR KR1019910700073A patent/KR0133553B1/ko not_active IP Right Cessation
- 1990-06-14 WO PCT/JP1990/000773 patent/WO1990015607A1/ja active IP Right Grant
- 1990-06-14 DE DE69028603T patent/DE69028603T2/de not_active Expired - Fee Related
- 1990-06-14 DK DK90909377.5T patent/DK0429676T3/da active
- 1990-06-14 AT AT90909377T patent/ATE142881T1/de active
Also Published As
Publication number | Publication date |
---|---|
WO1990015607A1 (fr) | 1990-12-27 |
EP0429676B1 (en) | 1996-09-18 |
CA2032487A1 (en) | 1990-12-17 |
KR920700645A (ko) | 1992-08-10 |
DE69028603D1 (de) | 1996-10-24 |
EP0429676A1 (en) | 1991-06-05 |
EP0429676A4 (en) | 1992-05-20 |
DE69028603T2 (de) | 1997-02-13 |
ATE142881T1 (de) | 1996-10-15 |
US5182276A (en) | 1993-01-26 |
KR0133553B1 (ko) | 1998-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20025517D0 (no) | Triazolderivater | |
NO900853D0 (no) | Slitebane for kjoeretoeydekk med midtre partier forsynt medskraa innsnitt. | |
GR3019450T3 (en) | Azaheterocyclylmethyl-chromans as agents for the treatment of diseases of the central nervous system | |
ATE227343T1 (de) | Protease und verwandte dns-verbindungen | |
EP0168234A3 (en) | Purification process for hepatitis surface antigen and product thereof | |
ATE222763T1 (de) | Verwendung von imidazo-(1,2-a)-pyridin-3-acetamid-derivaten für die therapeutische behandlung von neuropsychiatrischen syndromen in zusammenhang mit störungen der nervenbahnen der basalganglien | |
AU624471B2 (en) | Substituted quinolinecarboxylic acids | |
DK0429676T3 (da) | ||
ES2080736T3 (es) | Uso de 2,3,4,5-tetrahidro-1h-3-benzazepinas en el tratamiento de trastornos neurologicos. | |
RU94046220A (ru) | N/гетеро/-арил-n/гетеро/-тетралин-алкилпиперазин, обладающий серотонинергической, допаминергической и адренергической активностью, способ их получения, терапевтическая композиция, применение | |
EP0303391A3 (en) | Optical isomers of a spiroquinuclidine derivative | |
GR3015685T3 (en) | 5-Aryl-3H-1,2,4-triazol-3-ones and their use in the treatment of neurodegenerative disorders. | |
ATE350051T1 (de) | Verwendung von proteinen der midkine-familie in der behandlung von ischämischen krankheiten | |
AU574208B2 (en) | Temperature homogenisation of slabs | |
HU9201247D0 (en) | Process for the production of condensed diazepinone derivatives and of mnedical preparations containing them as active agents | |
HUT56559A (en) | Process for producing ascorbinic acid derivatives and pharma | |
FI93448C (fi) | Menetelmä terapeuttisesti käyttökelpoisen triatsolo/4,5-c/pyridiinijohdannaisten valmistamiseksi | |
ES2096035T3 (es) | Compuestos y procedimientos para el tratamiento de trastornos tromboembolicos. | |
ATE133865T1 (de) | Therapeutisches mittel für erkrankungen des zentralnervensystems |